Skip to content

Research on the Evaluation of Technical Specifications for the Treatment of Bacterial Pneumonia in Children by Qingfei Therapy Combined with Antibiotics

Research on the Evaluation of Technical Specifications for the Treatment of Bacterial Pneumonia in Children by Qingfei Therapy Combined with Antibiotics

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000735
Enrollment
Unknown
Registered
2024-11-25
Start date
2022-12-01
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bacterial pneumonia in children

Interventions

Experimental group:Antibiotics+Qingfei massage therapy

Sponsors

The First Affiliated Hospital of Henan University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 5 Years

Inclusion criteria

Inclusion criteria: 1)In line with the diagnostic criteria of Western medicine and TCM syndrome differentiation criteria for bacterial pneumonia in children; 2)1<Age = 5 years old gender is not limited; 3)Can be admitted to hospital for routine treatment; 4)The legal guardian of the child informed and agreed to receive treatment.

Exclusion criteria

Exclusion criteria: 1.Confirmed or suspected pneumonia caused by non-community-acquired bacterial pathogens; 2.Non-infectious causes of pulmonary infiltration such as pulmonary embolism chemical pneumonia caused by inhalation etc.; 3.Pleural empyema (excluding non-purulent pneumonic pleural effusion); 4.Including but not limited to pneumonia complicated by bronchial asthma bronchial foreign body pneumonia complicated by measles whooping cough influenza pneumonia complicated by other serious primary lung diseases; 5.Those who are allergic to ß-lactam antibiotics in the past; 6.Those who used antibiotics within 72 hours before enrollment; 7.Have a history of epilepsy or convulsions in the past except those with clearly recorded febrile convulsions in children; 8.Infection may require simultaneous use of systemic corticosteroids; 9.There is evidence of immediate life-threatening disease including but not limited to current or imminent respiratory failure acute heart failure shock acute liver failure active gastrointestinal bleeding; 10.Patients with primary diseases such as heart liver kidney digestive and hematopoietic systems; 11.Pneumonia combined with diarrhea; 12.Any situation that the researchers believe will compromise the safety of the patient or the quality of the data; 13.Those who are unable or unwilling to comply with the procedures and restrictions specified by the study.

Design outcomes

Primary

MeasureTime frame
Clinical cure rate;Days of antibiotic use;

Secondary

MeasureTime frame
Effective time for reducing fever coughing expectoration and relieving asthma;Reaching the incidence rate of indications for transfer to ICU;Efficacy of individual symptoms (fever cough expectoration asthma) and pulmonary signs;Disease efficacy;Incidence of antibiotic upgrade treatment;complete fever reduction days;Therapeutic effect of TCM syndrome;

Countries

China

Contacts

Public ContactMa Shuxia

The First Affiliated Hospital of Henan University of TCM

msx1562@126.com13673713879

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026